BIOGEN INC (IDP.DE) Stock Earnings Estimates
Europe - Frankfurt Stock Exchange - FRA:IDP - US09062X1037 - Common Stock
148.6 EUR
+2.7 (+1.85%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.173B -7.37% | 9.836B -3.32% | 9.676B -1.62% | 10.02B 3.56% | 9.508B -5.11% | 9.479B -0.31% | 9.561B 0.87% | 9.525B -0.38% | 9.429B -1.01% | 9.356B -0.77% | 9.414B 0.62% | 9.402B -0.13% | |
| EBITDA YoY % growth | 3.742B -6.03% | 2.669B -28.68% | 3.325B 24.56% | 3.266B -1.76% | 3.329B 1.93% | 3.169B -4.81% | 3.275B 3.34% | 3.316B 1.25% | 3.066B -7.54% | 3.853B 25.67% | 4.248B 10.25% | 4.69B 10.40% | |
| EBIT YoY % growth | 3.224B -7.75% | 2.174B -32.56% | 2.651B 21.94% | 2.851B 7.53% | 2.825B -0.91% | 2.914B 3.15% | 3.111B 6.76% | 3.102B -0.29% | 3.09B -0.39% | 3.159B 2.23% | 3.29B 4.15% | 3.118B -5.23% | |
| Operating Margin | 31.69% | 22.11% | 27.40% | 28.45% | 29.71% | 30.74% | 32.54% | 32.57% | 32.77% | 33.76% | 34.95% | 33.16% | |
| EPS YoY % growth | 18.45 -3.81% | 15.08 -18.27% | 16.47 9.22% | 15.23 -7.54% | 15.46 1.51% | 16.15 4.45% | 16.74 3.68% | 16.96 1.31% | 16.54 -2.48% | 17.18 3.85% | 17.92 4.35% | 17.49 -2.42% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.60 -53.53% | 3.61 19.37% | 4.04 -26.22% | 3.83 -20.47% | 3.41 113.35% | 4.14 14.87% | 4.40 8.94% | 4.60 20.26% | 4.62 35.47% |
| Revenue Q2Q % growth | 2.247B -8.46% | 2.317B -4.69% | 2.434B -7.99% | 2.428B -4.21% | 2.401B 6.85% | 2.315B -0.09% | 2.413B -0.86% | 2.434B 0.25% | 2.446B 1.87% |
| EBITDA Q2Q % growth | 385.56M -68.98% | 697.35M -19.12% | 788.46M -39.46% | 792.43M -37.80% | 915.25M 137.38% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 336.48M -40.98% | 639.93M -5.75% | 729.57M -21.12% | 719.5M 3.61% | 679.74M 102.01% | 712.98M 11.42% | 729.3M -0.04% | 737.46M 2.50% | 716.04M 5.34% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.81 17.89% | 3.96 | 0.85 | 21.48% |
| Q2 2025 Q2Q % growth | 5.47 3.60% | 3.94 | 1.53 | 38.92% |
| Q1 2025 Q2Q % growth | 3.02 -17.71% | 2.58 | 0.44 | 17.28% |
| Q4 2024 Q2Q % growth | 3.44 4.24% | 3.42 | 0.02 | 0.67% |
| Q3 2024 Q2Q % growth | 4.08 -6.42% | 3.87 | 0.21 | 5.50% |
| Q2 2024 Q2Q % growth | 5.28 31.34% | 4.11 | 1.17 | 28.61% |
| Q1 2024 Q2Q % growth | 3.67 7.94% | 3.52 | 0.15 | 4.32% |
| Q4 2023 Q2Q % growth | 3.30 -18.52% | 3.25 | 0.05 | 1.62% |
| Q3 2023 Q2Q % growth | 4.36 -8.60% | 4.05 | 0.31 | 7.59% |
| Q2 2023 Q2Q % growth | 4.02 -23.43% | 3.84 | 0.18 | 4.66% |
| Q1 2023 Q2Q % growth | 3.40 -22.37% | 3.34 | 0.06 | 1.66% |
| Q4 2022 Q2Q % growth | 4.05 19.47% | 3.55 | 0.50 | 13.99% |
| Q3 2022 Q2Q % growth | 4.77 | 4.22 | 0.55 | 13.06% |
| Q2 2022 Q2Q % growth | 5.25 -7.57% | 4.14 | 1.11 | 26.66% |
| Q1 2022 Q2Q % growth | 4.38 -17.98% | 4.47 | -0.09 | -1.93% |
| Q4 2021 Q2Q % growth | 3.39 -25.98% | 3.45 | -0.06 | -1.66% |
| Q3 2021 Q2Q % growth | 4.77 -46.04% | 4.17 | 0.60 | 14.44% |
| Q2 2021 Q2Q % growth | 5.68 -44.64% | 4.63 | 1.05 | 22.64% |
| Q1 2021 Q2Q % growth | 5.34 -41.58% | 5.14 | 0.20 | 3.81% |
| Q4 2020 Q2Q % growth | 4.58 | 4.97 | -0.39 | -7.80% |
| Q3 2020 Q2Q % growth | 8.84 | 8.20 | 0.64 | 7.80% |
| Q2 2020 Q2Q % growth | 10.26 | 8.19 | 2.07 | 25.23% |
| Q1 2020 Q2Q % growth | 9.14 | 7.89 | 1.25 | 15.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 2.535B 2.79% | 2.386B | 148.7M | 6.23% |
| Q2 2025 Q2Q % growth | 2.646B 7.33% | 2.37B | 275.5M | 11.62% |
| Q1 2025 Q2Q % growth | 2.431B 6.13% | 2.279B | 152M | 6.67% |
| Q4 2024 Q2Q % growth | 2.455B 2.87% | 2.452B | 2.7M | 0.11% |
| Q3 2024 Q2Q % growth | 2.466B -2.54% | 2.483B | -17M | -0.68% |
| Q2 2024 Q2Q % growth | 2.465B 0.36% | 2.429B | 35.9M | 1.48% |
| Q1 2024 Q2Q % growth | 2.291B -7.00% | 2.358B | -67.5M | -2.86% |
| Q4 2023 Q2Q % growth | 2.386B -6.20% | 2.514B | -127.7M | -5.08% |
| Q3 2023 Q2Q % growth | 2.53B 0.87% | 2.446B | 84.3M | 3.45% |
| Q2 2023 Q2Q % growth | 2.456B -5.14% | 2.412B | 44M | 1.82% |
| Q1 2023 Q2Q % growth | 2.463B -2.72% | 2.389B | 74M | 3.10% |
| Q4 2022 Q2Q % growth | 2.544B -6.94% | 2.491B | 53M | 2.13% |
| Q3 2022 Q2Q % growth | 2.509B -9.73% | 2.518B | -9.5M | -0.38% |
| Q2 2022 Q2Q % growth | 2.589B -6.70% | 2.522B | 67.1M | 2.66% |
| Q1 2022 Q2Q % growth | 2.532B -6.02% | 2.551B | -19.2M | -0.75% |
| Q4 2021 Q2Q % growth | 2.734B -4.16% | 2.669B | 64.8M | 2.43% |
| Q3 2021 Q2Q % growth | 2.779B -17.69% | 2.724B | 54.9M | 2.02% |
| Q2 2021 Q2Q % growth | 2.775B -24.63% | 2.657B | 118M | 4.44% |
| Q1 2021 Q2Q % growth | 2.694B -23.78% | 2.707B | -13M | -0.48% |
| Q4 2020 Q2Q % growth | 2.853B | 2.856B | -3.4M | -0.12% |
| Q3 2020 Q2Q % growth | 3.376B | 3.406B | -29.9M | -0.88% |
| Q2 2020 Q2Q % growth | 3.682B | 3.497B | 184.6M | 5.28% |
| Q1 2020 Q2Q % growth | 3.534B | 3.475B | 59.3M | 1.71% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.42% | -54.28% | 0.27% | -5.93% |
| Revenue | -0.09% | -2.47% | -0.05% | 1.53% |